Suchergebnisse - "Bujarski, Sean"

PubPharm (42)

1

A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone

enthalten in: Targeted oncology | 2024

von Berenson, J. | Limon, A. | Rice, S. | +16

2

The incidence of translocation t(11;14) among patients with multiple myeloma in a single clinic

enthalten in: American journal of clinical pathology | 2024

von Jew, S. | Goldwater, M. | Bujarski, S. | +6

3

Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective study

enthalten in: European journal of haematology | 2023

von Regidor, B. | Jew, S. | Goldwater, M. | +8

4

Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients

enthalten in: Targeted oncology | 2023

von Jew, S. | Bujarski, S. | Regidor, B. | +6

5

The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma

enthalten in: Hematological oncology | 2023

von Xu, N. | Yu, E. | Ng, N. | +11

6

Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma

enthalten in: Cancer reports (Hoboken, N.J.) | 2023

von Stampfer, S. | Bujarski, S. | Goldwater, M. | +10

7

Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma

enthalten in: British journal of haematology | 2023

von Berenson, J. | Martinez, D. | Safaie, T. | +13

8

Efficacy of venetoclax plus anti-CD38 monoclonal antibody-containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody

enthalten in: European journal of haematology | 2023

von Regidor, B. | Siddiqi, D. | Beatty, B. | +6

9

Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma

enthalten in: Clinical infection in practice | 2023

von Goldwater, M. | Stampfer, S. | Sean Regidor, B. | +7

10

Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma

enthalten in: British Journal of Haematology | 2023

von Berenson, J. | Martinez, D. | Safaie, T. | +13

1
2
3
4
5
Nächster »
[5]